The UK is one of the largest innovators and producers within biotechnology and pharmaceutical products with known multinationals providing treatments for large scale disease issues, newer companies providing batch customer medication and newer companies working with data and biotechnology researchers to provide customised medicines down to the individual level. The data and information now available with the advent of the Internet of Things and smart technologies has radically changed the way in which medicine and pharmacy can potentially be delivered in the future, opening up not just the possibility of customised medicines but also customised and specialist entrepreneurs within the field of biotech, pharmacy, and similar disciplines to provide high growth start up companies which address a real need for innovation within pharmacological areas and offer therapeutic treatments whilst we go about our every day lives.
Developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC) one of five innovation centres in Scotland some of which cross over in terms of innovation and technologies.Stratified Medicine holds huge potential to enhance timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new medicines.
If you are a person with ideas and a constant stream of research backing up your ideas and you have potential to be a company start up in this area the programme is directly aimed at getting your ideas off the ground and towards becoming a fully functioning enterprise in your own right in Scotland. You learn all there is to know about process innovation in order to progress your idea and samples through to small scale production testing whilst learning anything you didn't know about genome enabled medicines, biologic drug discovery, Pharmacokinetics and more. You get the best researchers to teach you as this programme is delivered in conjunction with the Stratified Medicine Scotland Innovation Centre partners.
You may be interested in reading about the Scottish Innovation Centres- http://www.innovationcentres.scot/innovation-centres/ to find out more information.
England Innovation Centres - https://catapult.org.uk/
Science Basis to Stratified Medicine
Commercialisation of Science
Application of Research and Evaluation Technologies
New Venture Creation
Applied Health Economics
Clinical Trials: Principles and Methods
Developing Research and Evaluation Skills
Quantitative Research Methods
Genome Enabled Medicine
Pharmacokinetics and Toxicokinetics
Biologic Drug Discovery
Find out more detail by visiting the programme web page
Find out about fees:
*Please be advised that some programmes have different tuition fees from those listed above and that some programmes also have additional costs.
View all funding options on our funding database via the programme page
Find out more about:
Find out more about living in Aberdeen:
The pharmaceutical and life sciences industries are investing in stem cells, either in direct applications where the stem cells themselves would be used for therapy or indirectly, where stem cell derived tissues will be used for drug screening and toxicity testing.
This programme is intended to meet current and future needs of the pharmaceutical industry and health care providers by providing a cadre of well-trained scientists capable of fulfilling managerial, administrative, research and technical roles within the developing commercial regenerative medicine sector.
Our programme covers key theoretical and practical aspects of the growth and maintenance of pluripotent stem cell lines, the directed differentiation of these cells into defined tissue phenotypes, and the maintenance of the differentiated state under conditions suitable for drug testing/screening programs.
Essential elements of good practice will also be included, such as quality assurance and the regulatory framework that surrounds the derivation, storage and use of human cells.
Our teaching is multidisciplinary, with contributions from the fields of medicine, biology, chemistry and bioinformatics.
The programme contains both taught and independent project components.
There will be an industrial placement of three months, situated within a life sciences company specialising in aspects of regenerative medicine. Financial assistance may be available to cover travel expenses to the location of the industrial placement.
Graduates will be equipped for a variety of roles within the developing commercial regenerative medicine sector.